Finch’s C. diff drug cleared of FDA hold, but loose ends leave timing for phase 3 restart unclear
Finch’s C. diff drug cleared of FDA hold, but loose [...]
AstraZeneca kicks off work on 1,500-person R&D center in Kendall Square
AstraZeneca kicks off work on 1,500-person R&D center in Kendall [...]
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout in wake of flagging stock
‘Serious missteps’: All Blue makes case for $773M Zymeworks buyout [...]
Chutes & Ladders—Merck loses another top exec, this time to Moderna
Chutes & Ladders—Merck loses another top exec, this time to [...]
With the makings of a hub, NYC primed to be life sciences leader
With the makings of a hub, NYC primed to be [...]
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching final two assets
UPDATE: Sio Gene Therapies warns of ‘significant’ layoffs after ditching [...]
Pfizer’s phase 3 DMD gene therapy test resumes after FDA hold, but decision on advanced patients still pending
Pfizer’s phase 3 DMD gene therapy test resumes after FDA [...]
Future shaky at Solid Bio as it shaves off 35% of workforce, chief operating officer plans exit
Future shaky at Solid Bio as it shaves off 35% [...]
BridgeBio strategy head departs amid company’s second round of layoffs this year
BridgeBio strategy head departs amid company’s second round of layoffs [...]
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics
2 become 1: Caladrius and Cend merge into tumor-focused Lisata [...]